Mandate

Vinge advises Fouriertransform in connection with investment in NovaCast Technologies

February 04, 2010

Vinge has advised Fouriertransform, the Swedish state-owned venture capital company for the automotive industry, in its acquisition of shares through a directed new share issue in NovaCast Technologies AB (publ). NovaCast Technologies, which is listed on Nasdaq OMX Stockholm (Small Cap), develops and markets products and software intended to improve the efficiency and speed of production processes to automotive industry companies and their sub-contractors.

The investment amounts to SEK 40 million and, if approved, will make Fouriertransform the largest individual shareholder. The issue is conditional upon approval by an extraordinary shareholders’ meeting.

Vinge’s team consisted of partner Göran Nyström and associates David Andersson and Caroline Strömbäck.

Related

Vinge advises Fortinova Fastigheter AB (publ) on its first SEK 200 million green bond issue

Vinge has advised Fortinova Fastigheter AB (publ) (“Fortinova”) on the company’s first issue of senior unsecured green bonds in an aggregate principal amount of SEK 200 million, under a framework of up to SEK 600 million. Nordea, acted as sole bookrunner in connection with the bond issue.
September 18, 2026

Vinge advises Morrow Bank AB (publ) in connection with the bank’s sale of parts of MedMera Bank and the sale of NPL portfolios

Vinge has advised Morrow Bank AB (publ) in connection with the divestment of parts of MedMera Bank’s operations to a leading global credit investment firm. The divestment is structured as a sale of shares and priced at a premium of approximately SEK 90 million above equity value as per the completion date. The transaction includes parts of MedMera’s banking operations such as IT infrastructure, organisation and management, whilst Morrow Bank retains MedMera’s performing loans, deposits, customers, the MedMera brand, the Coop partnership agreement as well as key personnel.
September 15, 2026

Vinge advises HealthCap in conjunction with its investment in AMRA Medical

HealthCap is investing in AMRA Medical AB, a company that analyses whole-body MRI images to classify and quantify an individual’s muscle and fat tissue throughout the body and places this in relation to human health and disease.
September 15, 2026